Fred Hassan, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 51,000 shares at $99.01 ($5.0M) on 2013-08-29, disclosed to the SEC on 2013-09-03.
Open-market purchase of $5.0M VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| XON | BUY | 2016-12-05 | $200K | — | Filing → |
| AMGN | BUY | 2015-08-20 | $502K | — | Filing → |
| TWX | BUY | 2010-03-04 | $1.0M | — | Filing → |